End Diagnostic Overshadowing
Recruiting
Observational Study
Disabilities Multiple
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 – 89
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120,000 (estimated)
- Sponsor
- Rush University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to address the critical issue of diagnostic overshadowing by applying the Collective Impact Model40 to co-produce our End Diagnostic Overshadowing program with academic, health systems, health professional, PWDs, family members, and community stakeholders. Through this work, we will identify and address mechanisms that contribute to diagnostic overshadowing and diagnostic…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
• Patients aged 3-89 who received billed charges
Exclusion Criteria:
* Patients under age 3 or over age 89.
* Patients with secondary diagnosis of dementia as the population is already known to be at increased risk of diagnostic error
Contacts